Patient to Appeal Sanofi Win in Taxotere Personal Injury Case

A woman alleging Sanofi-Aventis US LLC didn’t warn its breast cancer drug Taxotere could cause permanent hair loss plans to challenge a verdict in favor of the drugmaker, one of her attorneys said.

A jury in the U.S. District Court for the Eastern District of Louisiana found Sept. 26 that the product was not proven to cause a patient’s permanent baldness. It was the first case to be tried in a sweeping multidistrict litigation, which was formed three years ago and involves more than 11,000 pending lawsuits.

Despite the jury’s verdict, Barbara Earnest “believes that the overwhelming evidence supports her ...